Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron for Prevention of Postoperative Cognitive Dysfunction in Cardiac Surgery
NCT04195204Phase 4Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) comparing Tropisetron with Placebo (2 arms). Primary endpoint: Feasibility of tropisetron intervention on POCD at 30 days. Status: unknown.
02
Drugs
tropisetron
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04195204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195204.